Co-Founders Amogha Tadimety and Alison Burklund
2022 MBA Northeast
LinkedIn: Amogha Alison | Website
Molecular diagnostics company disrupting traditional testing methodologies for women.
Nanopath raises a $10M Series A
Nanopath, a Cambridge, Mass.-based women's health diagnostics company, raised $10m in Series A funding. Norwest Venture Partners and the Medtech Convergence Fund co-led, and were joined by Gingerbread Capital and Green D Ventures.Press Release